The current global system governing biotechnology has largely been shaped by Western hopes and fears and more research is needed into how developing countries view this new technology. This article compares two surveys that took place in the Philippines and Mexico and assesses some of the findings. Such results may be useful in developing integrated global risk and benefit management strategies.